David Claveau

David is a seasoned business development professional with over 25 years of experience in the pharmaceutical and biotech industries. He has held senior roles at companies such as Merck, Almirall, AstraZeneca, AVIR Pharma, and Ventus Therapeutics and has contributed to the development and commercialization of notable products, including Arcoxia™. Currently, David serves as Vice President, Business Development in North America at Sygnature Discovery, leading strategic partnerships and growth initiatives across the region. 

David holds a BSc in Biochemistry from Laval University and an MSc in Biomedical Sciences from the University of Montreal.